Danaparoid and blood urea increased Patient Reports February 10, 2010

Danaparoid Side Effects Report #5026915-1
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on June 05, 2006. Female patient, 92 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: blood urea increased, disseminated intravascular coagulation, gastrointestinal haemorrhage, haemoglobin decreased. Danaparoid dosage: unknown. During the same period patient was treated with CIPROFLOXACIN HYDROCHLORIDE, PRODIF, PLATELETS, PLASMA PROTEIN FRACTION, RED BLOOD CELLS, PLASMA PROTEIN FRACTION. Patient died.

Danaparoid Side Effects Report #5061700-6
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on July 10, 2006. Female patient, 88 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, blood potassium decreased, blood urea increased, c-reactive protein increased, fibrin d dimer increased, platelet count decreased, prothrombin time prolonged. Danaparoid dosage: unknown. During the same period patient was treated with POLYGLOBIN, PRIMAXIN, DOPAMINE, FLOMOXEF. Patient recovered.

Danaparoid Side Effects Report #5022100-8
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on May 23, 2006. Female patient, 88 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, blood potassium decreased, blood urea increased, c-reactive protein increased, fibrin d dimer increased, prothrombin time prolonged, thrombocytopenia. Danaparoid dosage: unknown. During the same period patient was treated with POLYGLOBIN, PRIMAXIN, DOPAMINE, FLOMOXEF. Patient recovered.

Danaparoid Side Effects Report #5118898-0
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Sept 19, 2006. Female patient, 82 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, blood urea increased, condition aggravated, haemoglobin decreased, pneumonia , upper gastrointestinal haemorrhage, white blood cell count increased. Danaparoid dosage: unknown. During the same period patient was treated with DORIPENEM HYDRATE, ROXATIDINE ACETATE. Patient died.


Danaparoid Side Effects Report #4976157-0
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Mar 27, 2006. Male patient, 80 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, blood urea increased, condition aggravated, gastrointestinal haemorrhage, haemorrhagic diathesis, hyperkalaemia, jaundice , white blood cell count decreased. Danaparoid dosage: unknown. During the same period patient was treated with PLASMA PROTEIN FRACTION, SULPERAZON, PREDNISOLONE ACETATE OPHTHALMIC, AZASETRON HYDROCHLORIDE, PIRARUBICIN, VINCRISTINE SULPHATE, CYCLOPHOSPHAMIDE, CARBENIN. Patient was hospitalized. Patient died.

Danaparoid Side Effects Report #4976160-0
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Dec 28, 2005. Male patient, 80 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, blood urea increased, jaundice , white blood cell count decreased. Danaparoid dosage: unknown. During the same period patient was treated with PLASMA PROTEIN FRACTION, SULPERAZON, PREDNISOLONE ACETATE OPHTHALMIC, AZASETRON HYDROCHLORIDE, PIRARUBICIN, VINCRISTINE SULPHATE, CYCLOPHOSPHAMIDE, CARBENIN. Patient died.

Danaparoid Side Effects Report #5083999-2
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Aug 07, 2006. Male patient, 78 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, anaemia, blood lactate dehydrogenase increased, blood potassium increased, blood urea increased, prothrombin time prolonged, subdural haemorrhage. Danaparoid dosage: unknown. During the same period patient was treated with MENATETRENONE, MAGNESIUM OXIDE, FAMOTIDINE, FUROSEMIDE, ALLOPURINOL. Patient died.

Danaparoid Side Effects Report #5029101-4
Danaparoid side effect was reported by a Health Professional from JAPAN on June 07, 2006. Male patient, 78 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, anaemia, blood lactate dehydrogenase increased, blood potassium increased, blood urea increased, platelet count decreased, prothrombin time prolonged, subdural haematoma. Danaparoid dosage: unknown. During the same period patient was treated with MENATETRENONE, MAGNESIUM OXIDE, FAMOTIDINE, FUROSEMIDE, ALLOPURINOL. Patient died.

Danaparoid Side Effects Report #4967758-4
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Mar 26, 2006. Female patient, 76 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: blood bilirubin increased, blood creatinine increased, blood potassium increased, blood urea increased, cardiac disorder, condition aggravated, haematocrit decreased, haemoglobin decreased, haemorrhage. Danaparoid dosage: unknown. During the same period patient was treated with PANCURONIUM BROMIDE, GABEXATE MESILATE, CEFOZOPRAN HYDROCHLORIDE, THEOPHYLLINE, PROPOFOL. Patient died.


Danaparoid Side Effects Report #5027829-3
Danaparoid side effect was reported by a Health Professional from JAPAN on June 01, 2006. Female patient, 76 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: blood bilirubin increased, blood creatinine increased, blood potassium increased, blood urea increased, cardiac disorder, condition aggravated, haematocrit decreased, haemoglobin decreased, haemorrhage. Danaparoid dosage: unknown. During the same period patient was treated with PANCURONIUM BROMIDE, GABEXATE MESILATE, CEFOZOPRAN HYDROCHLORIDE, THEOPHYLLINE, PROPOFOL. Patient died.

Danaparoid Side Effects Report #4568431-7
Danaparoid side effect was reported by a Consumer or non-health professional from on Jan 25, 2005. Female patient, 74 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, blood urea increased, sepsis . Danaparoid dosage: unknown. During the same period patient was treated with NAFAMOSTAT MESILATE, SOLDEM, PREDNISOLONE, FUROSEMIDE, RANITIDINE HYDROCHLORIDE, OMEPRAZOLE, HICALIQ, SOHVITA. Patient died.

Danaparoid Side Effects Report #4708472-X
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on June 28, 2005. Male patient, 72 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatinine increased, blood lactate dehydrogenase increased, blood urea increased, pancreatitis, white blood cell count increased. Danaparoid dosage: unknown. During the same period patient was treated with GABEXATE MESILATE, LEVOTHYROXINE, FERROUS FUMARATE, URSODEOXYCHOLIC ACID, GLYCYRRHIZIC ACID, GLUTATHIONE, VANCOMYCIN, FUROSEMIDE. Patient recovered.

Danaparoid Side Effects Report #4968089-9
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Mar 27, 2006. Male patient, 64 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, blood urea increased, cerebral haemorrhage, convulsion, liver disorder, loss of consciousness. Danaparoid dosage: unknown. During the same period patient was treated with TRANEXAMIC ACID, CARBAZOCHROME SULFONATE, MENATETRENONE, CEFMETAZOLE, OMEPRAZOLE, PENTAZOCINE LACTATE, HYDROXYZINE HYDROCHLORIDE, DEXAMETHASONE. Patient died.

Danaparoid Side Effects Report #5019637-4
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on May 24, 2006. Male patient, 64 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, blood urea increased, cerebral haemorrhage, convulsion, liver disorder, loss of consciousness, prothrombin time prolonged. Danaparoid dosage: unknown. During the same period patient was treated with TRANEXAMIC ACID, CARBAZOCHROME SULFONATE, MENATETRENONE, CEFMETAZOLE, OMEPRAZOLE, PENTAZOCINE LACTATE, HYDROXYZINE HYDROCHLORIDE, DEXAMETHASONE. Patient died.


Danaparoid Side Effects Report #5062431-9
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on July 07, 2006. Male patient, 58 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, anaemia, aspartate aminotransferase increased, blood albumin decreased, blood fibrinogen increased, blood lactate dehydrogenase increased, blood potassium decreased, blood urea increased, fibrin d dimer increased. Danaparoid dosage: unknown. During the same period patient was treated with TRANEXAMIC ACID, DAUNOMYCIN, CYTARABINE, ANTITHROMBIN III, MINOPHAGEN C, CEFTAZIDIME. Patient recovered.

Danaparoid Side Effects Report #5063640-5
Danaparoid side effect was reported by a Physician from JAPAN on July 06, 2006. Male patient, 56 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: blood bilirubin increased, blood creatinine increased, blood urea increased, condition aggravated, haemoglobin decreased, upper gastrointestinal haemorrhage, white blood cell count increased. Danaparoid dosage: unknown. During the same period patient was treated with NAFAMOSTAT MESILATE, ANTITHROMBIN III, FAMOTIDINE. Patient died.

Danaparoid Side Effects Report #5030650-3
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on May 25, 2006. Male patient, 30 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: blood fibrinogen abnormal, blood urea increased, cystitis haemorrhagic, cystitis viral, haematuria, proteinuria. Danaparoid dosage: unknown. During the same period patient was treated with HEPARIN, NEUPOGEN, CYCLOSPORINE, CEFEPIME HYDROCHLORIDE, FLUCONAZOLE, ACYCLOVIR, GAMIMUNE N, MEROPENEM. Patient was hospitalized. Patient recovered.